- Estimation of failure probabilities in the presence of competing risks: new representations of old estimatorsT A Gooley
Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA 98109 1024, USA
Stat Med 18:695-706. 1999....
- Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experienceU Yusuf
Fred Hutchinson Cancer Research Center and University of Washington Department of Pediatrics, Seattle, WA 98109, USA
Bone Marrow Transplant 33:805-14. 2004..5 times more likely to relapse (P=0.01). The median follow-up among the 43 surviving patients is 10 years (range 1-25). We conclude that allogeneic BMT for children with MDS is well tolerated and can be curative...
- Outcome of allogeneic bone marrow transplantation for children with advanced acute myeloid leukemiaE R Nemecek
Department of Pediatrics, Clinical Research Division, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA 98109, USA
Bone Marrow Transplant 34:799-806. 2004..Survival for children transplanted in CR2 or untreated first relapse is higher than that previously reported, but relapse remains the major cause of treatment failure regardless of disease stage...
- Imatinib therapy prior to myeloablative allogeneic stem cell transplantationJ M Zaucha
Department of Hematology, Medical University of Gdansk, Gdansk, Poland
Bone Marrow Transplant 36:417-24. 2005..65, P = 0.60). These data do not provide any evidence that imatinib preceding HSCT increases acute transplant-related toxicities...